Zafgen

$0.7345
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0266 (3.78%) Today
+$0.0049 (0.67%) As of 7:15 PM EDT after-hours

Why Robinhood?

You can buy or sell Zafgen and other stocks, options, ETFs, and crypto commission-free!

About ZFGN

Zafgen, Inc. Common Stock, also called Zafgen, is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. Read More It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA.

Employees
38
Headquarters
Boston, Massachusetts
Founded
2005
Market Cap
27.27M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.73M
High Today
$0.7345
Low Today
$0.7051
Open Price
$0.71
Volume
823.54K
52 Week High
$12.36
52 Week Low
$0.63

Collections

ZFGN Earnings

-$0.59
-$0.50
-$0.41
-$0.32
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.